Evidence map›Paper›PMID 38861965›Full record

ArticleThe American journal of tropical medicine and hygiene2024

Case Report: First Report of Mucocutaneous Leishmaniasis in Algeria: Observations from a Case Report.

Nacera Seklaoui, Arezki Izri, Islam Tablit, Mustapha Chergou, Boussad Hamrioui, Mohammad Akhoundi

Abstract readCase Reports
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Mucosal Leishmaniasis in Tunisia: Observations from a Rare Case Report.The American journal of tropical medicine and hygiene · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nacera SeklaouiParasitology-Mycology Department, Hospital-University of Nedir Mohammed, Tizi-Ouzou, Algeria.
Arezki IzriParasitology-Mycology Department, Avicenne Hospital, Sorbonne Paris Nord University, Bobigny, France.
Islam TablitDermatology Department, Hospital-University of Nedir Mohammed, Tizi-Ouzou, Algeria.
Mustapha ChergouParasitology-Mycology Department, Hospital-University of Nedir Mohammed, Tizi-Ouzou, Algeria.
Boussad HamriouiParasitology-Mycology Department, Hospital-University of Nedir Mohammed, Tizi-Ouzou, Algeria.
Mohammad AkhoundiParasitology-Mycology Department, Avicenne Hospital, Sorbonne Paris Nord University, Bobigny, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the first case of mucocutaneous leishmaniasis in Algeria, diagnosed in an immunocompetent 42-year-old man exhibiting an infiltrated and ulcerated plaque leading to macrocheilitis of the entire lower lip. He was a police officer who lived in a village in Ain El Hammam (Kabylie region, known as an active focus of zoonotic visceral leishmaniasis) without any history of travel for the previous 3 years. He suffered from cutaneous lesions for 22 months due to the misdiagnosis of a skin lesion resembling other diseases such as Crohn disease or sarcoidosis. A compilation of clinical, histopathological, parasitological, and molecular examinations revealed Leishmania infantum as the etiologic agent. The patient was treated with meglumine antimoniate, which resulted in the complete disappearance of the lesion 4 months after treatment.

Indexed as

Antiprotozoal AgentsLeishmania infantumLeishmaniasis, MucocutaneousMeglumine AntimoniateAdultAlgeriaHumansMaleMeglumineOrganometallic CompoundsAntiprotozoal AgentsMeglumineMeglumine AntimoniateOrganometallic Compounds

Identifiers

PMID38861965
PMCPMC11310627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.